Annual report 2022
We create added value for the healthcare system.
Key figures
With its Annual report 2022, Galenica is publishing a combined annual and sustainability report based on the GRI Standard with full annual economic, social and environmental data.
Financial key figures
4'014.3
Net sales
in million CHF
200.8
EBIT adjusted1
in million CHF
2.20
Dividend
in CHF per share
Key social figures
7’608
Number of employees
as of 31.12.2022
4.6
Investment in employee development
in million CHF
99.0%
Availability of medicinal products
on average 2022
Key environmental figures
44%
Energy consumption
from renewable sources
10.77
Energy intensity
in MWh/FTE
43%
Waste is recycled
on average 2022
Highlights 2022
Management report
Galenica achieves sales of more than CHF 4 billion for the first time
With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted1 EBIT of CHF 200.8 million (-5.8%), Galenica achieved very good results. Excluding the extraordi-nary results in the previous year from the COVID-19 initiatives (estimated at CHF 25 million) and the sale of property at the headquarters in Berne (CHF 9.4 million), adjusted1 EBIT growth amounted to a healthy 12.4%.
Major advances in sustainability
We firmly believe that our Group can achieve long-term economic success only if we also bear social responsibility and use natural resources efficiently and respectfully. In the 2022 financial year, Galenica continued to implement specific measures to achieve the sus-tainability goals.
«Last year, we further strengthened the important role of the pharmacy as a point of contact for health issues.»
Virginie Pache, Chief Pharmacies Officer